2023 Q4 Form 10-Q Financial Statement

#000113778923000128 Filed on October 27, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $1.555B $1.454B
YoY Change -17.59% -44.67%
Cost Of Revenue $1.193B $1.305B
YoY Change -27.3% -30.18%
Gross Profit $362.0M $149.0M
YoY Change 47.15% -80.37%
Gross Profit Margin 23.28% 10.25%
Selling, General & Admin $108.0M $105.0M
YoY Change -13.6% -29.53%
% of Gross Profit 29.83% 70.47%
Research & Development $161.0M $171.0M
YoY Change -19.5% -30.77%
% of Gross Profit 44.48% 114.77%
Depreciation & Amortization $62.00M $76.00M
YoY Change -58.11% -40.16%
% of Gross Profit 17.13% 51.01%
Operating Expenses $269.0M $276.0M
YoY Change -17.23% -30.65%
Operating Profit $124.0M -$129.0M
YoY Change -177.5% -135.73%
Interest Expense $84.00M $84.00M
YoY Change 9.09% -231.25%
% of Operating Profit 67.74%
Other Income/Expense, Net -$128.0M -$18.00M
YoY Change -204.92% 20.0%
Pretax Income -$4.000M -$147.0M
YoY Change -89.47% -152.31%
Income Tax $15.00M $37.00M
% Of Pretax Income
Net Earnings -$19.00M -$184.0M
YoY Change -42.42% -166.67%
Net Earnings / Revenue -1.22% -12.65%
Basic Earnings Per Share -$0.09 -$0.88
Diluted Earnings Per Share -$0.09 -$0.88
COMMON SHARES
Basic Shares Outstanding 209.2M shares 207.4M shares
Diluted Shares Outstanding 209.0M shares 208.0M shares

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $787.0M $795.0M
YoY Change 2.21% 29.27%
Cash & Equivalents $787.0M $795.0M
Short-Term Investments
Other Short-Term Assets $317.0M $268.0M
YoY Change 14.44% -16.51%
Inventory $1.053B $1.052B
Prepaid Expenses
Receivables $471.0M $521.0M
Other Receivables $122.0M $109.0M
Total Short-Term Assets $2.628B $2.636B
YoY Change -14.7% -34.64%
LONG-TERM ASSETS
Property, Plant & Equipment $1.642B $1.652B
YoY Change -22.62% -26.22%
Goodwill $1.237B $1.237B
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments $26.00M $55.00M
YoY Change -54.39% -9.84%
Other Assets $568.0M $584.0M
YoY Change 96.54% 98.64%
Total Long-Term Assets $4.521B $4.560B
YoY Change -5.54% -7.15%
TOTAL ASSETS
Total Short-Term Assets $2.628B $2.636B
Total Long-Term Assets $4.521B $4.560B
Total Assets $7.149B $7.196B
YoY Change -9.13% -19.54%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.619B $1.511B
YoY Change 49.22% -26.58%
Accrued Expenses $743.0M $790.0M
YoY Change -10.37% 32.55%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $0.00
YoY Change -100.0% -100.0%
Total Short-Term Liabilities $2.529B $2.473B
YoY Change -7.19% -30.44%
LONG-TERM LIABILITIES
Long-Term Debt $5.669B $5.666B
YoY Change 5.12% 11.93%
Other Long-Term Liabilities $679.0M $667.0M
YoY Change 406.72% 394.07%
Total Long-Term Liabilities $6.348B $6.333B
YoY Change 14.85% 21.86%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.529B $2.473B
Total Long-Term Liabilities $6.348B $6.333B
Total Liabilities $8.963B $8.898B
YoY Change 7.51% 0.71%
SHAREHOLDERS EQUITY
Retained Earnings -$9.194B -$9.025B
YoY Change 17.12% 26.81%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.814B -$1.702B
YoY Change
Total Liabilities & Shareholders Equity $7.149B $7.196B
YoY Change -9.13% -19.54%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income -$19.00M -$184.0M
YoY Change -42.42% -166.67%
Depreciation, Depletion And Amortization $62.00M $76.00M
YoY Change -58.11% -40.16%
Cash From Operating Activities $169.0M $127.0M
YoY Change -32.67% -29.44%
INVESTING ACTIVITIES
Capital Expenditures $70.00M $70.00M
YoY Change -188.61% -197.22%
Acquisitions
YoY Change
Other Investing Activities $35.00M $0.00
YoY Change 1650.0% -100.0%
Cash From Investing Activities -$35.00M -$70.00M
YoY Change -54.55% 18.64%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $1.288B
YoY Change
Cash From Financing Activities -142.0M -$49.00M
YoY Change -13.94% -92.39%
NET CHANGE
Cash From Operating Activities 169.0M $127.0M
Cash From Investing Activities -35.00M -$70.00M
Cash From Financing Activities -142.0M -$49.00M
Net Change In Cash -8.000M $9.000M
YoY Change -188.89% -101.72%
FREE CASH FLOW
Cash From Operating Activities $169.0M $127.0M
Capital Expenditures $70.00M $70.00M
Free Cash Flow $99.00M $57.00M
YoY Change -70.0% -77.38%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1305000000 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
171000000 usd
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
105000000 usd
CY2023Q3 stx Amortizationofintangibleassetsexcludingamountincludedincostofrevenue
Amortizationofintangibleassetsexcludingamountincludedincostofrevenue
0 usd
CY2022Q3 stx Amortizationofintangibleassetsexcludingamountincludedincostofrevenue
Amortizationofintangibleassetsexcludingamountincludedincostofrevenue
3000000 usd
CY2023Q3 us-gaap Restructuring Charges
RestructuringCharges
2000000 usd
CY2022Q3 us-gaap Restructuring Charges
RestructuringCharges
9000000 usd
CY2022Q3 us-gaap Costs And Expenses
CostsAndExpenses
1928000000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
107000000 usd
CY2022Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
1000000 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
71000000 usd
CY2022Q3 stx Gain Loss On Termination Of Interest Rate Swap Net
GainLossOnTerminationOfInterestRateSwapNet
0 usd
CY2022Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-10000000 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-80000000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
27000000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2000000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
29000000 usd
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.14
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.14
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
208000000 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
210000000 shares
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
29000000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1000000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1000000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-113000000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
37000000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-297000000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
66000000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-184000000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
29000000 usd
CY2023Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
76000000 usd
CY2022Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
135000000 usd
CY2023Q3 us-gaap Share Based Compensation
ShareBasedCompensation
25000000 usd
CY2022Q3 us-gaap Share Based Compensation
ShareBasedCompensation
29000000 usd
CY2023Q3 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
28000000 usd
CY2022Q3 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-5000000 usd
CY2023Q3 us-gaap Gain Loss On Repurchase Of Debt Instrument
GainLossOnRepurchaseOfDebtInstrument
-7000000 usd
CY2022Q3 us-gaap Gain Loss On Repurchase Of Debt Instrument
GainLossOnRepurchaseOfDebtInstrument
0 usd
CY2023Q3 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
50000000 usd
CY2022Q3 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-13000000 usd
CY2023Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-100000000 usd
CY2022Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-434000000 usd
CY2023Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-88000000 usd
CY2022Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
41000000 usd
CY2023Q3 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-70000000 usd
CY2022Q3 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-300000000 usd
CY2023Q3 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-12000000 usd
CY2022Q3 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-146000000 usd
CY2023Q3 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
54000000 usd
CY2022Q3 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
4000000 usd
CY2023Q3 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-65000000 usd
CY2022Q3 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-93000000 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
127000000 usd
CY2022Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
245000000 usd
CY2023Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
70000000 usd
CY2022Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
133000000 usd
CY2023Q3 us-gaap Proceeds From Sale Of Other Assets Investing Activities
ProceedsFromSaleOfOtherAssetsInvestingActivities
0 usd
CY2022Q3 us-gaap Proceeds From Sale Of Other Assets Investing Activities
ProceedsFromSaleOfOtherAssetsInvestingActivities
1000000 usd
CY2023Q3 us-gaap Payments To Acquire Assets Investing Activities
PaymentsToAcquireAssetsInvestingActivities
0 usd
CY2022Q3 us-gaap Payments To Acquire Assets Investing Activities
PaymentsToAcquireAssetsInvestingActivities
1000000 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-70000000 usd
CY2022Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-133000000 usd
CY2023Q3 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1288000000 usd
CY2022Q3 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 usd
CY2023Q3 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
145000000 usd
CY2022Q3 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
147000000 usd
CY2023Q3 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 usd
CY2022Q3 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
408000000 usd
CY2023Q3 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
25000000 usd
CY2022Q3 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
39000000 usd
CY2023Q3 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
1500000000 usd
CY2022Q3 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
600000000 usd
CY2023Q3 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
35000000 usd
CY2022Q3 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
29000000 usd
CY2023Q3 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-126000000 usd
CY2022Q3 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-1000000 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-49000000 usd
CY2022Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
34000000 usd
CY2023Q3 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1000000 usd
CY2022Q3 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
9000000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
146000000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
788000000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
617000000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
797000000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
763000000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-1199000000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-113000000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
35000000 usd
CY2023Q3 stx Adjustments To Additional Paid In Capital Capped Call Options Issuance Of Convertible Notes
AdjustmentsToAdditionalPaidInCapitalCappedCallOptionsIssuanceOfConvertibleNotes
95000000 usd
CY2023Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
25000000 usd
CY2023Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.70
CY2023Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
146000000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
25000000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-1702000000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
109000000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
29000000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
37000000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
29000000 usd
CY2022Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
400000000 usd
CY2022Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
39000000 usd
CY2022Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.70
CY2022Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
145000000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
29000000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-351000000 usd
CY2023Q3 us-gaap Fiscal Period
FiscalPeriod
The Company operates and reports financial results on a fiscal year of 52 or 53 weeks ending on the Friday closest to June 30. In fiscal years with 53 weeks, the first quarter consists of 14 weeks and the remaining quarters consist of 13 weeks each. Both the three months ended September 29, 2023 and September 30, 2022 consisted of 13 weeks. Fiscal years 2024 and 2023 both comprise 52 weeks and end on June 28, 2024 and June 30, 2023, respectively. The fiscal quarters ended September 29, 2023, June 30, 2023 and September 30, 2022, are also referred to herein as the “September 2023 quarter”, the “June 2023 quarter” and the “September 2022 quarter”, respectively.
CY2023Q3 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
Other Long-Lived Assets<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with its policy, the Company reviews the estimated useful lives of its fixed assets on an ongoing basis. Effective from the first quarter of fiscal year 2024, the Company changed the useful lives of certain manufacturing equipment from a range of <span style="-sec-ix-hidden:f-262">three</span> to seven years to a range of <span style="-sec-ix-hidden:f-264">three</span> to ten years based on its review of technology product roadmap. The effect of this change in estimate increased the net income and diluted earnings per share by approximately </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$10 million and $0.05, respectively,</span> for the three months ended September 29, 2023.
CY2023Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
137000000 usd
CY2023Q3 us-gaap Debt Securities Available For Sale Accumulated Gross Unrealized Gain Loss Before Tax
DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax
0 usd
CY2023Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
137000000 usd
CY2023Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
90000000 usd
CY2023Q2 us-gaap Debt Securities Available For Sale Accumulated Gross Unrealized Gain Loss Before Tax
DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax
0 usd
CY2023Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
90000000 usd
CY2023Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
137000000 usd
CY2023Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
90000000 usd
CY2023Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
2000000 usd
CY2023Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
2000000 usd
CY2023Q3 us-gaap Debt Securities Available For Sale Unrealized Loss Position Number Of Positions
DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
0 usd
CY2023Q2 us-gaap Debt Securities Available For Sale Unrealized Loss Position Number Of Positions
DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
0 usd
CY2023Q3 us-gaap Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
0 usd
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities Next Rolling Twelve Months Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis
122000000 usd
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities Next Rolling Twelve Months Fair Value
AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue
122000000 usd
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities Rolling Year Two Through Five Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis
15000000 usd
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities Rolling Year Two Through Five Fair Value
AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue
15000000 usd
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities Rolling Year Six Through Ten Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCostBasis
0 usd
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities Rolling Year Six Through Ten Fair Value
AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue
0 usd
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities Rolling After Year Ten Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesRollingAfterYearTenAmortizedCostBasis
0 usd
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities Rolling After Year Ten Fair Value
AvailableForSaleSecuritiesDebtMaturitiesRollingAfterYearTenFairValue
0 usd
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis
137000000 usd
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
137000000 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
795000000 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
786000000 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
761000000 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
615000000 usd
CY2023Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
2000000 usd
CY2023Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
2000000 usd
CY2022Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
2000000 usd
CY2022Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
2000000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
797000000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
788000000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
763000000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
617000000 usd
CY2023Q3 us-gaap Transfer Of Financial Assets Accounted For As Sales Cash Proceeds Received For Assets Derecognized Amount
TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount
292000000 usd
CY2023Q3 us-gaap Securitized Assets And Any Other Financial Assets Managed Together Principal Amount Outstanding
SecuritizedAssetsAndAnyOtherFinancialAssetsManagedTogetherPrincipalAmountOutstanding
363000000 usd
CY2022Q3 us-gaap Transfer Of Financial Assets Accounted For As Sales Cash Proceeds Received For Assets Derecognized Amount
TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount
200000000 usd
CY2022Q3 us-gaap Securitized Assets And Any Other Financial Assets Managed Together Principal Amount Outstanding
SecuritizedAssetsAndAnyOtherFinancialAssetsManagedTogetherPrincipalAmountOutstanding
237000000 usd
CY2023Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
243000000 usd
CY2023Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
241000000 usd
CY2023Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
657000000 usd
CY2023Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
682000000 usd
CY2023Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
152000000 usd
CY2023Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
217000000 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
1052000000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
1140000000 usd
CY2023Q3 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
109000000 usd
CY2023Q2 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
167000000 usd
CY2023Q3 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
159000000 usd
CY2023Q2 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
191000000 usd
CY2023Q3 us-gaap Other Assets Current
OtherAssetsCurrent
268000000 usd
CY2023Q2 us-gaap Other Assets Current
OtherAssetsCurrent
358000000 usd
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
10260000000 usd
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
10267000000 usd
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
8608000000 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
8561000000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1652000000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1706000000 usd
CY2023Q3 stx Restructuring And Related Cost Accelerated Depreciation And Other
RestructuringAndRelatedCostAcceleratedDepreciationAndOther
13000000 usd
CY2022Q3 stx Restructuring And Related Cost Accelerated Depreciation And Other
RestructuringAndRelatedCostAcceleratedDepreciationAndOther
22000000 usd
CY2023Q3 us-gaap Dividends Payable Current
DividendsPayableCurrent
146000000 usd
CY2023Q2 us-gaap Dividends Payable Current
DividendsPayableCurrent
145000000 usd
CY2023Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
644000000 usd
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
603000000 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
790000000 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
748000000 usd
CY2023Q3 stx Capped Call Transaction Price Per Share
CappedCallTransactionPricePerShare
107.848
CY2023Q3 stx Capped Call Transaction Premium
CappedCallTransactionPremium
0.70
CY2023Q3 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
63.44
CY2023Q3 stx Adjustments To Additional Paid In Capital Capped Call Options Issuance Of Convertible Notes
AdjustmentsToAdditionalPaidInCapitalCappedCallOptionsIssuanceOfConvertibleNotes
95000000 usd
CY2019Q3 stx Debt Instrument Covenant Minimum Liquidity
DebtInstrumentCovenantMinimumLiquidity
700000000 usd
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
0 usd
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
479000000 usd
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
0 usd
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
505000000 usd
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
1500000000 usd
CY2023Q3 stx Long Term Debt Maturity After Year Four
LongTermDebtMaturityAfterYearFour
3245000000 usd
CY2023Q3 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
5729000000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
37000000 usd
CY2023Q3 us-gaap Tax Adjustments Settlements And Unusual Provisions
TaxAdjustmentsSettlementsAndUnusualProvisions
33000000 usd
CY2023Q3 us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
-9000000 usd
CY2023Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
107000000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2000000 usd
CY2022Q3 us-gaap Tax Adjustments Settlements And Unusual Provisions
TaxAdjustmentsSettlementsAndUnusualProvisions
-7000000 usd
CY2023Q3 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.25
CY2022Q3 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.25
CY2023Q3 us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
2000000 usd
CY2022Q3 us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
9000000 usd
CY2022Q4 us-gaap Restructuring And Related Cost Number Of Positions Eliminated
RestructuringAndRelatedCostNumberOfPositionsEliminated
480 numberofemployees
CY2023Q2 us-gaap Restructuring And Related Cost Number Of Positions Eliminated Inception To Date
RestructuringAndRelatedCostNumberOfPositionsEliminatedInceptionToDate
3480 numberofemployees
CY2023Q3 us-gaap Restructuring Reserve Accrual Adjustment1
RestructuringReserveAccrualAdjustment1
-1000000 usd
CY2023Q3 stx Gain Loss On Termination Of Interest Rate Swap Net
GainLossOnTerminationOfInterestRateSwapNet
104000000 usd
CY2023Q2 us-gaap Equity Method Investments
EquityMethodInvestments
55000000 usd
CY2022Q3 stx Net Gains Losses From Investment Under Measurement Alternative
NetGainsLossesFromInvestmentUnderMeasurementAlternative
3000000 usd
CY2023Q3 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
0 usd
CY2023Q3 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
18000000 usd
CY2023Q2 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
23000000 usd
CY2023Q2 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
11000000 usd
CY2022Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-3000000 usd
CY2023Q3 us-gaap Equity Method Investments
EquityMethodInvestments
55000000 usd
CY2023Q3 stx Authorized Share Capital Common And Preferred Stock Value
AuthorizedShareCapitalCommonAndPreferredStockValue
13500 usd
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1250000000 shares
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
209181031 shares
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q3 us-gaap Common Stock Voting Rights
CommonStockVotingRights
one vote per share
CY2023Q3 stx Preferred Stock Minimum Number Of Series
PreferredStockMinimumNumberOfSeries
1
CY2023Q3 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
1900000000 usd
CY2023Q3 us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
0 shares
CY2023Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
25000000 usd
CY2023Q3 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
0 shares
CY2023Q3 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
25000000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1454000000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2035000000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1454000000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2035000000 usd
CY2023Q3 stx Intellectual Property Indemnification Obligations
IntellectualPropertyIndemnificationObligations
0 usd
CY2023Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
168000000 usd
CY2022Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
148000000 usd
CY2023Q3 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
13000000 usd
CY2022Q3 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
13000000 usd
CY2023Q3 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
18000000 usd
CY2022Q3 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
24000000 usd
CY2023Q3 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
13000000 usd
CY2022Q3 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
12000000 usd
CY2023Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
176000000 usd
CY2022Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
149000000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-184000000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
29000000 usd
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
208000000 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
208000000 shares
CY2023Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2022Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2000000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
208000000 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
210000000 shares
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.88
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.14
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.88
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.14
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6000000 shares
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2023Q2 stx Loss Contingency Settlement Amount
LossContingencySettlementAmount
300000000 usd
CY2023Q2 stx Loss Contingency Settlement Quarterly Installments Amount
LossContingencySettlementQuarterlyInstallmentsAmount
15000000 usd
CY2023Q2 stx Loss Contingency Settlement Terms Period Of Payments
LossContingencySettlementTermsPeriodOfPayments
P5Y
CY2023Q2 stx Loss Contingency Settlement Number Of Audits
LossContingencySettlementNumberOfAudits
3 audit
CY2023Q2 stx Loss Contingency Number Of Third Party Audits
LossContingencyNumberOfThirdPartyAudits
1 audit
CY2023Q2 stx Loss Contingency Settlement Number Of Internal Audits
LossContingencySettlementNumberOfInternalAudits
2 audit
CY2023Q2 stx Loss Contingency Settlement Suspended Denial Order Period
LossContingencySettlementSuspendedDenialOrderPeriod
P5Y
CY2022Q3 us-gaap Loss Contingency Loss In Period
LossContingencyLossInPeriod
300000000 usd
CY2023Q3 us-gaap Unrecorded Unconditional Purchase Obligation Balance Sheet Amount
UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount
2600000000 usd
CY2023Q3 us-gaap Unrecorded Unconditional Purchase Obligation Balance On Second Anniversary
UnrecordedUnconditionalPurchaseObligationBalanceOnSecondAnniversary
184000000 usd
CY2023Q3 us-gaap Unrecorded Unconditional Purchase Obligation Balance On Third Anniversary
UnrecordedUnconditionalPurchaseObligationBalanceOnThirdAnniversary
223000000 usd
CY2023Q3 us-gaap Unrecorded Unconditional Purchase Obligation Balance On Fourth Anniversary
UnrecordedUnconditionalPurchaseObligationBalanceOnFourthAnniversary
1500000000 usd
CY2023Q3 us-gaap Unrecorded Unconditional Purchase Obligation Balance On Fifth Anniversary
UnrecordedUnconditionalPurchaseObligationBalanceOnFifthAnniversary
739000000 usd
CY2023Q3 stx Recorded Unconditional Purchase Obligation Order Cancellation Fees
RecordedUnconditionalPurchaseObligationOrderCancellationFees
118000000 usd
CY2023Q3 stx Recorded Unconditional Purchase Obligation Accrued Order Cancellation Fees
RecordedUnconditionalPurchaseObligationAccruedOrderCancellationFees
151000000 usd
CY2023Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001137789-23-000128-index-headers.html Edgar Link pending
0001137789-23-000128-index.html Edgar Link pending
0001137789-23-000128.txt Edgar Link pending
0001137789-23-000128-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
stx-20230929.htm Edgar Link pending
stx-20230929.xsd Edgar Link pending
stx-ex103_20230927xfinal.htm Edgar Link pending
stx-ex311_20230929.htm Edgar Link pending
stx-ex312_20230929.htm Edgar Link pending
stx-ex321_20230929.htm Edgar Link pending
stx-20230929_cal.xml Edgar Link unprocessable
stx-20230929_def.xml Edgar Link unprocessable
stx-20230929_lab.xml Edgar Link unprocessable
stx-20230929_pre.xml Edgar Link unprocessable
stx-20230929_htm.xml Edgar Link completed